These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22436042)

  • 1. Letter: thiopurines during pregnancy and intrauterine exposure to metabolites.
    de Boer NK; Jharap B; Seinen ML; van Bodegraven AA
    Aliment Pharmacol Ther; 2012 Apr; 35(8):964-5; author reply 965-6. PubMed ID: 22436042
    [No Abstract]   [Full Text] [Related]  

  • 2. Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease.
    Jharap B; de Boer NK; Stokkers P; Hommes DW; Oldenburg B; Dijkstra G; van der Woude CJ; de Jong DJ; Mulder CJ; van Elburg RM; van Bodegraven AA;
    Gut; 2014 Mar; 63(3):451-7. PubMed ID: 23424097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Table: safety of drugs for IBD in pregnancy.
    Med Lett Drugs Ther; 2018 Jul; 60(1550):e116. PubMed ID: 30036355
    [No Abstract]   [Full Text] [Related]  

  • 4. Fertility and pregnancy in inflammatory bowel disease.
    Alstead E
    World J Gastroenterol; 2001 Aug; 7(4):455-9. PubMed ID: 11819810
    [No Abstract]   [Full Text] [Related]  

  • 5. The fetal safety of thiopurines for the treatment of inflammatory bowel disease in pregnancy.
    Hutson JR; Matlow JN; Moretti ME; Koren G
    J Obstet Gynaecol; 2013 Jan; 33(1):1-8. PubMed ID: 23259868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study.
    Coelho J; Beaugerie L; Colombel JF; Hébuterne X; Lerebours E; Lémann M; Baumer P; Cosnes J; Bourreille A; Gendre JP; Seksik P; Blain A; Metman EH; Nisard A; Cadiot G; Veyrac M; Coffin B; Dray X; Carrat F; Marteau P;
    Gut; 2011 Feb; 60(2):198-203. PubMed ID: 21115547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of inflammatory bowel disease.
    Jafri SM
    J Pak Med Assoc; 1990 Jul; 40(7):162-7. PubMed ID: 2125661
    [No Abstract]   [Full Text] [Related]  

  • 8. Preterm birth in women with inflammatory bowel disease - the association with disease activity and drug treatment.
    Bröms G; Granath F; Stephansson O; Kieler H
    Scand J Gastroenterol; 2016 Dec; 51(12):1462-1469. PubMed ID: 27739352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiopurine therapy: when to start and when to stop.
    McGovern DP; Travis SP
    Eur J Gastroenterol Hepatol; 2003 Mar; 15(3):219-23. PubMed ID: 12610314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of children exposed intrauterine to maternal thiopurine therapy during pregnancy in females with inflammatory bowel disease.
    de Meij TG; Jharap B; Kneepkens CM; van Bodegraven AA; de Boer NK;
    Aliment Pharmacol Ther; 2013 Jul; 38(1):38-43. PubMed ID: 23675854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. My treatment approach to management of the pregnant patient with inflammatory bowel disease.
    Ng SW; Mahadevan U
    Mayo Clin Proc; 2014 Mar; 89(3):355-60. PubMed ID: 24582194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiopurines during pregnancy in inflammatory bowel disease: is there a risk for the (unborn) child?
    de Boer NK; de Meij T; van Bodegraven AA
    Expert Rev Gastroenterol Hepatol; 2013 Nov; 7(8):669-71. PubMed ID: 24134152
    [No Abstract]   [Full Text] [Related]  

  • 13. Transplacental transfer of immunosuppressants and biologics used for the treatment of inflammatory bowel disease.
    Chaparro M; Gisbert JP
    Curr Pharm Biotechnol; 2011 May; 12(5):765-73. PubMed ID: 21342120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of pregnancies fathered by inflammatory bowel disease patients exposed to thiopurines.
    Teruel C; López-San Román A; Bermejo F; Taxonera C; Pérez-Calle JL; Gisbert JP; Martín-Arranz M; Ponferrada A; Van Domselaar M; Algaba A; Estellés J; López-Serrano P; Linares PM; Muriel A
    Am J Gastroenterol; 2010 Sep; 105(9):2003-8. PubMed ID: 20700117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical management of the pregnant patient with inflammatory bowel disease.
    Steinlauf AF; Present DH
    Gastroenterol Clin North Am; 2004 Jun; 33(2):361-85, xi. PubMed ID: 15177544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthy offspring in parents both receiving thiopurines.
    Oefferlbauer-Ernst A; Reinisch W; Miehsler W; Vogelsang H; Dejaco C
    Gastroenterology; 2004 Feb; 126(2):628. PubMed ID: 14765398
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel disease.
    Casanova MJ; Chaparro M; Domènech E; Barreiro-de Acosta M; Bermejo F; Iglesias E; Gomollón F; Rodrigo L; Calvet X; Esteve M; García-Planella E; García-López S; Taxonera C; Calvo M; López M; Ginard D; Gómez-García M; Garrido E; Pérez-Calle JL; Beltrán B; Piqueras M; Saro C; Botella B; Dueñas C; Ponferrada A; Mañosa M; García-Sánchez V; Maté J; Gisbert JP
    Am J Gastroenterol; 2013 Mar; 108(3):433-40. PubMed ID: 23318480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful Pregnancies with Thiopurine-Allopurinol Co-Therapy for Inflammatory Bowel Disease.
    Sheikh M; Nelson-Piercy C; Duley J; Florin T; Ansari A
    J Crohns Colitis; 2015 Aug; 9(8):680-4. PubMed ID: 25939351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inflammatory bowel diseases: conservative therapy].
    Bansky G
    Ther Umsch; 1991 Jul; 48(7):464-70. PubMed ID: 1926006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory bowel disease and pregnancy.
    Lamah M; Scott HJ
    Int J Colorectal Dis; 2002 Jul; 17(4):216-22. PubMed ID: 12073069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.